Table 1. Demographic and clinical characteristics of the cohort with and without convalescent plasma.
Characteristics | All | Convalescent plasma | p-value | |
---|---|---|---|---|
(N = 94) n (%) |
No (n = 21) n (%) |
Yes (n = 73) n (%) |
||
Age, mean ± SD, years | 50.0 ± 15.0 | 53.0 ± 17.0 | 51.0 ± 15.0 | 0.644 |
Gender, male | 85 (90.4) | 19 (90.5) | 66 (90.4) | 0.993 |
Smoking, past/present | 4 (4.3) | 1 (4.8) | 3 (4.1) | 1.000 |
Hypertension | 35 (37.2) | 8 (38.1) | 27 (37.0) | 0.926 |
Diabetes mellitus | 34 (36.2) | 11 (52.4) | 23 (31.5) | 0.079 |
Chronic lung disease | 1 (1.1) | 1 (4.8) | 0 (0.0) | 0.223 |
Chronic heart disease | 7 (7.4) | 1 (4.8) | 6 (8.2) | 1.000 |
Chronic renal disease | 3 (3.2) | 1 (4.8) | 2 (2.7) | 0.536 |
Asthma | 2 (2.1) | 0 (0.0) | 2 (2.7) | 1.000 |
Pneumonia | 20 (21.3) | 2 (9.5) | 18 (24.7) | 0.135 |
Severe pneumonia | 7 (7.4) | 0 (0.0) | 7 (9.6) | 0.343 |
Sepsis/septic shock | 8 (8.5) | 0 (0.0) | 8 (11.0) | 0.192 |
X-ray findings | ||||
Bilateral consolidations | 69 (73.3) | 13 (61.9) | 56 (76.7) | 0.261 |
Patchy reticular infiltrations | 22 (23.4) | 5 (23.8) | 17 (23.3) | 1.000 |
SOFA score | 5 (3–7) | 6 (2–9) | 5 (3–7) | 0.475 |
n (%) unless specified otherwise.
SD: standard deviation; SOFA: sequential organ failure assessment.